One-year follow-up data from Phase 2 trial of once-weekly canvuparatide, a potential best-in-class therapy for ...
If you ever find a personal or work task daunting, you might just need to rethink how you approach it. Pomodoro apps and ...
Why BorgWarner’s Fair Value Tweaks Matter Analysts have inched BorgWarner’s modeled fair value to about US$50.00 per share, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback